+499.5%
MRNA vs BBIO
+44.0%
+455.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | BBIO | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.8% | -1.5% | -1.9% |
| 7D | +5.5% | -2.3% | +7.8% | +6.5% |
| 30D | +158.7% | -8.7% | +167.5% | +169.8% |
| 3M | +182.1% | +11.2% | +171.0% | +178.7% |
| 6M | +151.8% | +12.5% | +139.3% | +147.7% |
| YTD | +393.6% | -2.2% | +395.7% | +402.0% |
| 1Y | +499.5% | +44.4% | +455.1% | +445.2% |
| All | +499.5% | +44.0% | +455.5% | +445.2% |
Cumulative growth
Daily Returns
Daily percentage return beside BBIO.
Daily Out/Under-Performance
Portfolio return minus BBIO return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × BBIO return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded BBIO wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling